Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Rontalizumab in Patients With Moderately to Severely Active Systemic Lupus Erythematosus [Phase 2]

View source ↗

Summary

Phase 2 study of rontalizumab in adults with moderately to severely active systemic lupus erythematosus has completed, focusing on efficacy and safety. The spon…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Rontalizumab (rontalizumab)

Snippet

Sponsor: Genentech, Inc. | Conditions: Systemic Lupus Erythematosus | Phase 2 | Status: COMPLETED